SynthesisThe oncologist2020

Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.

Jad Chahoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.